January, 16 2025 Thursday 00:20 Hrs
  • SENSEX :   76,724.08

  • Commodity broking firm in India224.45( 0.29%) 15-Jan-2025
top-arrow-market
Sensex 76724.08 224.45  (0.29) 15-Jan-2025
Previous Day Close
76499.63
Today's High/Low
High Low
  •  
  •  
76991.05 76479.7

Company News Details

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
513.6236355
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
86.67
159224.07
EPS(TTM)
Face Value()
Div & Yield %
69.2
2
0.5
 

divis laboratories ltd
Divis Laboratories commences commercial operations of a part of Unit III greenfield project
Jan 02,2025
Divis Laboratories has commenced commercial operations from a part of the Phase I of Unit III greenfield project at Ontimamidi Village (Kona), Thondangi Mandal, Kakinada, Andhra Pradesh from 01 January 2025.

The phase I of the Unit III greenfield project of the Company at Kakinada, Andhra Pradesh is being implemented on 200 acres of 500 acres Unit III site, with an estimated investment between Rs 1,200 crore to Rs 1,500 crore.

Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.